Signa Sa De Cv, based in Mexico, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is LACOSAMIDE, with a corresponding US DMF Number 26484.
Remarkably, this DMF maintains an Active status since its submission on September 27, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 26, 2013, and payment made on November 13, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II